Valeritas Featured on Fox Business Network’s Top Morning Show

Fox Business Network's show "Mornings with Maria" featured firm client Valeritas Holdings, Inc. In the segment, Valeritas CEO John Timberlake discussed the V-Go daily insulin delivery device, which is the only such device worn as a patch, and is meant to make life easier for those with Type 2 diabetes. John Timberlake was joined by Joe …

Continue reading Valeritas Featured on Fox Business Network’s Top Morning Show

ConforMIS Receives FDA Clearance for iTotal Hip Replacement System

Firm client ConforMIS, Inc. received FDA 510(k) clearance for its primary iTotal Hip replacement system. Chief Executive Officer and President Mark Augusti remarked: Having treated over 50,000 patients with customized knee replacement implants, ConforMIS brings over a decade of experience in patient-specific technology to the hip replacement market. FDA clearance of iTotal Hip demonstrates the ability …

Continue reading ConforMIS Receives FDA Clearance for iTotal Hip Replacement System

WatchRx Selected as Top Innovator by AARP and MedCity News

Jayanthi Narasimhan, Founder and CEO of firm client WatchRx, has been named a 50+ Innovation Leader by AARP and MedCity News. The honor recognizes the leading innovators of services and products designed to serve the booming 50+ consumer health market. Those who made the list were selected by their peers by voting. Modernizing patient care to …

Continue reading WatchRx Selected as Top Innovator by AARP and MedCity News

MBBP Client MindChild Medical, Inc. Receives FDA Clearance of Fetal Heart Monitor

MindChild Medical, Inc., a client of MBBP, has received FDA clearance for its Pre-Marketing Notification (510(k)) for its MERIDIAN™ M110 non-invasive fetal heart monitor. The FDA clearance will enable MindChild to enter the U.S. market with MERIDIAN™. MindChild's MERIDIAN™ M110 Fetal Monitoring System is an intrapartum fetal monitor that externally measures and displays fetal heart …

Continue reading MBBP Client MindChild Medical, Inc. Receives FDA Clearance of Fetal Heart Monitor

MBBP’s Client Abpro Collaborating with MedImmune on Medical Advancement

MBBP's client Abpro, a pioneer in the field of industrial biochemistry, has recently entered into a Collaboration Agreement with MedImmune, the global biologics research and development arm of AstraZeneca. The collaboration will advance the development of a preclinical, novel bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor (Ang2-VEGF). Abpro will contribute its strong scientific, technical and clinical expertise …

Continue reading MBBP’s Client Abpro Collaborating with MedImmune on Medical Advancement

MBBP Client Harvard Making Breakthroughs in Blood Stem Cell Research

Harvard University has recently completed a license agreement with Magenta Therapeutics, a newly launched start-up in Cambridge, Massachusetts, in order to continue research and development related to new approaches to blood stem cell transplantation. The deal will help transform this science from that of a "last resort" into safer, more effective therapy for patients who suffer from blood diseases, …

Continue reading MBBP Client Harvard Making Breakthroughs in Blood Stem Cell Research

Client Paragonix Technologies Enters Into Distribution Agreement with Pacific West Medical Sales for Paragonix SherpaPak™ Transport Systems

MBBP client, Paragonix Technologies Inc. recently entered into an exclusive distribution agreement with Pacific West Medical Sales to market Paragonix Technologies' SherpaPakTM Cardiac and Kidney Transport Systems. The SherpaPakTM Cardiac and Kidney Transport Systems are innovative medical devices that are indicated for the static hypothermic preservation of donor hearts and kidneys during transportation and eventual transplantation into a recipient. …

Continue reading Client Paragonix Technologies Enters Into Distribution Agreement with Pacific West Medical Sales for Paragonix SherpaPak™ Transport Systems

Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

A group of Boston-area health institutions, known as the Boston Autologous Islet Replacement Program, are teaming up to develop, test and deploy stem cells to cure diabetes. The group includes the Harvard Stem Cell Institute, Brigham and Women's Hospital, the Joslin Diabetes Center, Dana-Farber Cancer Institute and Semma Therapeutics. The innovation began when Doug Melton, Co-Director …

Continue reading Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

Interview with MBBP Client Valeritas Included in Wall Street Transcript Medical Devices Report

The most recent Wall Street Transcript Medical Devices Report includes an interview with Valeritas, Inc.'s CEO, John Timberlake.  Timberlake discusses in detail Valeritas's V-Go Disposable Insulin Delivery Device. The V-Go is a wearable basal-bolus insulin delivery device that allows patients to deliver insulin at a continuous preset basal rate, with bolus delivery as needed.  The V-Go …

Continue reading Interview with MBBP Client Valeritas Included in Wall Street Transcript Medical Devices Report

Client Corista Selected by Johns Hopkins Medicine to Extend Pathology Capabilities

Exciting news for MBBP client Corista as Johns Hopkins Medicine, one of the leading health care systems in the United States, has successfully installed Corista's DP3 system. The DP3 is a digital pathology network platform that removes the physical boundaries from pathology and enables real-time remote expert diagnoses. It is a workflow solution integrating multiple facilities, scanners, …

Continue reading Client Corista Selected by Johns Hopkins Medicine to Extend Pathology Capabilities